Probiotic applications of two dominant gut Bacillus strains with antagonistic activity improved the growth performance and immune responses of grouper Epinephelus coioides.
- 2010-11
- Fish & Shellfish Immunology 29(5)
- Yun‐Zhang Sun
- Hong-Ling Yang
- Ru-Long Ma
- Wenhui Lin
- PubMed: 20637875
- DOI: 10.1016/j.fsi.2010.07.018
Abstract
The effect of dietary administration of Bacillus pumilus and Bacillus clausii, the dominant bacteria with antagonistic activity in the gut of fast growing fish, on the growth performance and immune responses of grouper Epinephelus coioides were assessed. The fish were fed for 60 days with three different diets: control (without probiotics), diet T1 supplemented with 1.0x10(8) cells g(-1) B. pumilus, diet T2 with 1.0x10(8) cells g(-1) B. clausii. No significant improvements of weight gain or specific growth rate were observed in the probiotic fed groups, but a significant improvement of feed conversion ratio was observed after 60 days of feeding. Phagocytic activity and phagocytic index of fish fed probiotic diets were significantly higher than those of fish fed the control diet for 60 days. Superoxide dismutase (SOD) concentrations showed no significant difference between the treatments and the control during the whole experiment period, but which increased by 11.4% and 18.5% after 60 days of fed with diets T1 and T2, respectively. The serum lysozyme activities of fish fed diets T1 and T2 were significantly higher than that of fish fed control diet, and had respectively increased by 34.7% and 17.4% compared to the control after 60 days of feeding. Serum complement C3 levels of the treatments were significantly higher than that of control after 30 days of feeding, but no significant difference in serum complement C3 and C4 levels were observed between the treatments and the control after 60 days of feeding. The serum IgM levels of fish fed diet T1 and diet T2 were higher than that of fish fed control diet, and significant increase was observed in fish fed diet T2 for 30 days. The results demonstrated potential for B. pumilus and B. clausii to improve growth performance and immune responses of E. coioides.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Bacillus clausii | Elevated Complement C3 Levels | Beneficial | Moderate |
Bacillus clausii | Elevated Serum IgM Levels | Beneficial | Small |
Bacillus clausii | Improved Feed Conversion Ratio | Beneficial | Moderate |
Bacillus clausii | Increased PMN Cell Phagocytic Capacity | Beneficial | Moderate |
Bacillus clausii | Increased Serum Lysozyme Activity | Beneficial | Moderate |
Bacillus clausii MTCC 5980 | Elevated Complement C3 Levels | Beneficial | Moderate |
Bacillus clausii MTCC 5980 | Elevated Serum IgM Levels | Beneficial | Small |
Bacillus clausii MTCC 5980 | Improved Feed Conversion Ratio | Beneficial | Moderate |
Bacillus clausii MTCC 5980 | Improved Phagocytic Activity | Beneficial | Large |
Bacillus clausii MTCC 5980 | Increased Serum Lysozyme Activity | Beneficial | Moderate |
Bacillus clausii SC-109 | Elevated Serum IgM Levels | Beneficial | Small |
Bacillus clausii SC-109 | Improved Feed Conversion Ratio | Beneficial | Moderate |
Bacillus clausii SC-109 | Increased PMN Cell Phagocytic Capacity | Beneficial | Moderate |
Bacillus clausii SC-109 | Increased Serum Lysozyme Activity | Beneficial | Moderate |
Bacillus clausii SNZ-1971 | Elevated Complement C3 Levels | Beneficial | Moderate |
Bacillus clausii SNZ-1971 | Elevated Serum IgM Levels | Beneficial | Small |
Bacillus clausii SNZ-1971 | Improved Feed Conversion Ratio | Beneficial | Moderate |
Bacillus clausii SNZ-1971 | Increased PMN Cell Phagocytic Capacity | Beneficial | Moderate |
Bacillus clausii SNZ-1971 | Increased Serum Lysozyme Activity | Beneficial | Moderate |
Bacillus coagulans GBI-30, 6086 | Elevated Complement C3 Levels | Beneficial | Moderate |
Bacillus coagulans GBI-30, 6086 | Elevated Serum IgM Levels | Beneficial | Small |
Bacillus coagulans GBI-30, 6086 | Improved Feed Conversion Ratio | Beneficial | Moderate |
Bacillus coagulans GBI-30, 6086 | Increased Serum Lysozyme Activity | Beneficial | Moderate |